![Frontiers | PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer Frontiers | PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer](https://www.frontiersin.org/files/Articles/644737/fonc-11-644737-HTML-r1/image_m/fonc-11-644737-g001.jpg)
Frontiers | PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Mutant PIK3CA sensitizes HCT-116 human colon cancer cells to lithium... | Download Scientific Diagram
PIK3CA Activating Mutation in Colorectal Carcinoma: Associations with Molecular Features and Survival | PLOS ONE
![Summary for our hypothesis in MEK inhibitor-resistant PIK3CA mt colon... | Download Scientific Diagram Summary for our hypothesis in MEK inhibitor-resistant PIK3CA mt colon... | Download Scientific Diagram](https://www.researchgate.net/publication/332206862/figure/fig1/AS:878701914882049@1586510270088/Summary-for-our-hypothesis-in-MEK-inhibitor-resistant-PIK3CA-mt-colon-cancer-cells-These.png)
Summary for our hypothesis in MEK inhibitor-resistant PIK3CA mt colon... | Download Scientific Diagram
![Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020 | Published in healthbook TIMES Oncology Hematology Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020 | Published in healthbook TIMES Oncology Hematology](https://s3.amazonaws.com/production.scholastica/public/attachments/6f812987-bc0f-4f71-adc7-a95bef81a839/small/image2.png)
Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020 | Published in healthbook TIMES Oncology Hematology
![PIK3CA C-terminal frameshift mutations are novel oncogenic events that sensitize tumors to PI3K-α inhibition | PNAS PIK3CA C-terminal frameshift mutations are novel oncogenic events that sensitize tumors to PI3K-α inhibition | PNAS](https://www.pnas.org/cms/10.1073/pnas.2000060117/asset/5cba60a9-f2ee-4f46-9737-fa7d0af3c282/assets/images/large/pnas.2000060117fig04.jpg)
PIK3CA C-terminal frameshift mutations are novel oncogenic events that sensitize tumors to PI3K-α inhibition | PNAS
![PIK3CA Mutations Drive Therapeutic Resistance in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer | JCO Precision Oncology PIK3CA Mutations Drive Therapeutic Resistance in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer | JCO Precision Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/po/2022/po.2022.6/po.21.00370/20220329/images/keyimage.jpg)
PIK3CA Mutations Drive Therapeutic Resistance in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer | JCO Precision Oncology
![Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited | Cellular and Molecular Life Sciences Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited | Cellular and Molecular Life Sciences](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00018-022-04430-y/MediaObjects/18_2022_4430_Fig4_HTML.png)
Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited | Cellular and Molecular Life Sciences
![Aspirin has a better effect on PIK3CA mutant colorectal cancer cells by PI3K/Akt/Raptor pathway | Molecular Medicine | Full Text Aspirin has a better effect on PIK3CA mutant colorectal cancer cells by PI3K/Akt/Raptor pathway | Molecular Medicine | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs10020-020-0139-5/MediaObjects/10020_2020_139_Fig1_HTML.png)
Aspirin has a better effect on PIK3CA mutant colorectal cancer cells by PI3K/Akt/Raptor pathway | Molecular Medicine | Full Text
![Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited | Cellular and Molecular Life Sciences Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited | Cellular and Molecular Life Sciences](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00018-022-04430-y/MediaObjects/18_2022_4430_Fig2_HTML.png)
Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited | Cellular and Molecular Life Sciences
![Cancers | Free Full-Text | PIK3CA Gene Mutations in Solid Malignancies: Association with Clinicopathological Parameters and Prognosis Cancers | Free Full-Text | PIK3CA Gene Mutations in Solid Malignancies: Association with Clinicopathological Parameters and Prognosis](https://www.mdpi.com/cancers/cancers-12-00093/article_deploy/html/images/cancers-12-00093-g001.png)
Cancers | Free Full-Text | PIK3CA Gene Mutations in Solid Malignancies: Association with Clinicopathological Parameters and Prognosis
![PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer | Cell Death & Disease PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer | Cell Death & Disease](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41419-018-0776-6/MediaObjects/41419_2018_776_Fig1_HTML.jpg)
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer | Cell Death & Disease
![Cancers | Free Full-Text | Deactivation of Glutaminolysis Sensitizes PIK3CA-Mutated Colorectal Cancer Cells to Aspirin-Induced Growth Inhibition Cancers | Free Full-Text | Deactivation of Glutaminolysis Sensitizes PIK3CA-Mutated Colorectal Cancer Cells to Aspirin-Induced Growth Inhibition](https://www.mdpi.com/cancers/cancers-12-01097/article_deploy/html/images/cancers-12-01097-g006.png)
Cancers | Free Full-Text | Deactivation of Glutaminolysis Sensitizes PIK3CA-Mutated Colorectal Cancer Cells to Aspirin-Induced Growth Inhibition
PIK3CA Mutations Frequently Coexist with RAS and BRAF Mutations in Patients with Advanced Cancers | PLOS ONE
![Prognostic value of the PIK3CA, AKT, and PTEN mutations in oral squamous cell carcinoma: literature review Prognostic value of the PIK3CA, AKT, and PTEN mutations in oral squamous cell carcinoma: literature review](https://www.archivesofmedicalscience.com/f/fulltexts/91676/AMS-17-1-91676-g001.jpg)